Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
Sponsor: University of Louisville
Summary
The purpose of our study is to evaluate the efficacy and safety of different volumes of bladder-numbing medication for pain relief at the time of office bladder Botox injections. This is a randomized prospective, double-blind superiority trial comparing 200 ml 2% lidocaine versus 30 ml 2% lidocaine for office Botox injections.
Official title: Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections: a Prospective Randomized Superiority Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2024-12-01
Completion Date
2025-12-01
Last Updated
2024-11-19
Healthy Volunteers
No
Conditions
Interventions
Lidocaine 2% without vessel constrictor
different volumes of intravesical 2% lidocaine without epinephrine, all patients will be receiving bladder botox but this will not be compared
Locations (1)
University of Louisville Division of Urogynecology and Reconstructive Pelvic Surgery
Louisville, Kentucky, United States